Comparison Chart Akeso, Inc.

Equities

9926

KYG0146B1032

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 01:39:20 10/04/2026 pm IST			5-day change	1st Jan Change
138.20 ^HKD	+1.99%		-1.64%	+22.30%

07/04	Akeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L)1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026	CI
31/03	Akeso, Inc. Announces the Results of Health-Related Quality of Life Data from the HARMONi-2 Study At the 2026 European Lung Cancer Congress	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes